Early response and remission with benralizumab in patients with severe asthma and chronic rhinosinusitis with nasal polyposis (CRSwNP) in the prospective real-world imPROve Asthma study

Background Severe asthma and CRSwNP can involve similar histopathological changes and inflammatory mediator infiltration, and a combination is a difficult-to-treat phenotype.